Outcomes | Number of outcomes/Total number of patients | Â | Hazard Ratio (HR) (95%CI) | P-value$ | |
---|---|---|---|---|---|
Dexamethasone | Methylprednisolone | P-value | |||
30-day mortality, n (%) | 62 (34.8) | 25 (41.7) | 0.3417^^ | 0.997 (0.970, 1.025) | 0.85 |
In-hospital mortality, n (%) | 64 (35.6) | 29 (46.8) | 0.1173^^ | 1.02 (1.0, 1.04) | 0.05 |
 |  |  |  | beta coefficient (Estimates) (95%CI) | P-value$* |
MODS at day 3 of ICU admission, Median (Q1,Q3) ∆ | 5.0 (3.00, 8.00) | 6.0 (4.00, 9.00) | 0.1151^ | 0.17 (0.02,0.32) | 0.03 |
VFDs, Median (Q1,Q3) | 18.0 (0.00, 27.00) | 14.0 (0.00, 27.00) | 0.4849^ | -0.12 (-0.62,0.39) | 0.65 |
ICU Length of Stay (Days), Median (Q1,Q3) | 10.0 (6.00, 18.00) | 10.0 (7.00, 18.00) | 0.7702^ | 0.06 (-0.14,0.25) | 0.56 |
Hospital Length of Stay (Days), Median (Q1,Q3) | 17.0 (11.00, 26.00) | 19.0 (13.00, 27.00) | 0.6576^ | -0.15 (-0.35,0.05) | 0.14 |